Iovance Biotherapeutics to Present at Two Investor Conferences in June
May 31 2018 - 8:01AM
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology
company developing novel cancer immunotherapies based on
tumor-infiltrating lymphocyte (TIL) technology, today announced
that company management will present at two investor conferences in
June:
- Jefferies 2018 Global Healthcare Conference in
New York, NY on Thursday, June 7, 2018 at 9:00 a.m. ET
- JMP Securities Life Sciences Conference in New
York, NY on Wednesday, June 20, 2018 at 1:00 p.m. ET
A live audio webcast of both presentations will be available by
visiting the Investors section of Iovance
Biotherapeutics' website at http://ir.iovance.com/. A
replay of the webcasts will be archived on Iovance Biotherapeutics’
website for 30 days following the presentations.
About Iovance Biotherapeutics, Inc. Iovance
Biotherapeutics, Inc. is a clinical-stage biotechnology company
focused on the development of cancer immunotherapy products for the
treatment of various cancers. The company's lead product candidate
is an adoptive cell therapy using tumor-infiltrating lymphocyte
(TIL) technology being investigated for the treatment of patients
with metastatic melanoma, recurrent and/or metastatic squamous cell
carcinoma of the head and neck, recurrent, metastatic or persistent
cervical cancer, and locally advanced or metastatic non-small cell
lung cancer. For more information, please
visit http://www.iovance.com.
Investor Relations Contact: Sarah McCabe Stern
Investor Relations, Inc. 212-362-1200 sarah@sternir.com
Media Contact: Evan Smith FTI Consulting
212-850-5622 evan.smith@fticonsulting.com
Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Apr 2023 to Apr 2024